References
- TakeuchiKSodaMTogashiYRET, ROS1 and ALK fusions in lung cancerNat Med201218337838122327623
- BergethonKShawATOuSHIROS1 rearrangements define a unique molecular class of lung cancersJ Clin Oncol201230886387022215748
- ShawATOuSHBangYJCrizotinib in ROS1-rearranged non–small-cell lung cancerN Engl J Med1971372719631971
- AwadMMKatayamaRMctigueMAcquired resistance to crizotinib from a mutation in CD74–ROS1N Engl J Med2013368252395240123724914
- RimkunasVMCrosbyKELiDAnalysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusionClin Cancer Res201218164449445722661537
- LeeJLeeSEKangSYIdentification of ROS1 rearrangement in gastric adenocarcinomaCancer201311991627163523400546
- YoshidaAKohnoTTsutaKROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical casesAm J Surg Pathol201337455456223426121
- DaviesKDLeATTheodoroMFIdentifying and targeting ROS1 gene fusions in non-small cell lung cancerClin Cancer Res201218174570457922919003
- YoshidaATsutaKWakaiSImmunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancersMod Pathol201427571172024186139
- ShanLLianFGuoLDetection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCRPLoS One2014103e0120422
- SueharaYArcilaMWangLIdentification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusionsClin Cancer Res201218246599660823052255
- CaiWLiXSuCROS1 fusions in Chinese patients with non-small-cell lung cancerAnn Oncol20132471822182723514723
- PeraldoNCCavalloniGBalsamoAScreening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCRGenes Chromosomes Cancer201453121033104025231053
- PikorLARamnarineVRLamSLamWLGenetic alterations defining NSCLC subtypes and their therapeutic implicationsLung Cancer201382217918924011633
- YamaguchiNLucenaaraujoARNakayamaSDual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancerLung Cancer2014831374324199682
- PanYZhangYLiYALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic featuresLung Cancer201484212112624629636
- LukasRVHasanYNicholasMKSalgiaRROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapyJ Clin Neurosci201522121978197926159887
- LeXFreedJAVanderlaanPADetection of crizotinib-sensitive lung adenocarcinomas with MET, ALK, and ROS1 genomic alterations via comprehensive genomic profilingClin Lung Cancer2015165e105e10925922291
- BoyleTAMasagoKEllisonKEYatabeYHirschFRROS1 immunohistochemistry among major genotypes of non-small-cell lung cancerClin Lung Cancer201516210611125467930
- AliSMHensingTSchrockABComprehensive genomic profiling identifies a subset of crizotinib-responsive ALK-rearranged non-small cell lung cancer not detected by fluorescence in situ hybridizationOncologist201621676277027245569